MAPT and Alzheimer disease: Although aberrant serine and threonine phosphorylation of Tau is well-established in the pathology of AD and other tauopathies (66), the contributions of tyrosine phosphorylation to Tau pathology and Tau-mediated toxicity in these disorders remain poorly understood.